Colorado SB140: Exempt Drugs from Rx Drug Affordability Bd Reviews

What the bill says

A bill FOR AN ACT CONCERNING EXEMPTING CERTAIN DRUGS FROM THE SCOPE OF AFFORDABILITY REVIEWS CONDUCTED BY THE COLORADO PRESCRIPTION DRUG AFFORDABILITY REVIEW BOARD. Bill Summary (Note: This summary applies to this bill as introduced and does not reflect any amendments that may be subsequently adopted…

From the introduced text:

A BILL FOR AN ACT CONCERNING EXEMPTING CERTAIN DRUGS FROM THE SCOPE OF AFFORDABILITY REVIEWS CONDUCTED BY THE COLORADO PRESCRIPTION DRUG AFFORDABILITY REVIEW BOARD. Bill Summary (Note: This summary applies to this bill as introduced and does not reflect any amendments that may be subsequently adopted. If this bill passes third reading in the house of introduction, a bill summary that applies to the reengrossed version of this bill will be available at http://leg.colorado.gov.) The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is: ! Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal Shading denotes HOUSE amendment. Double underlining denotes SENATE amendment. Capital letters or bold & italic numbers indicate new material to be added to existing law. Dashes through the words or numbers indicate deletions from existing law. department of health and human services; or ! A licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA. Be it enacted by the General Assembly of the State of Colorado: SECTION 1. In Colorado Revised Statutes, amend 10-16-1415 as follows: 10-16-1415. Exemptions - prescription …

Read the full official text

Sponsors

• Gilchrist, Lindsay (D, 8) · primary sponsor
• Johnson, Dusty (R, 63) · primary sponsor
• Bradfield, Mary (R, 21)
• Hartsook, Anthony (R, 44)
• Joseph, Junie (D, 10)
• Taggart, Rick (R, 55)
• Frizell, Lisa (R, 2) · primary sponsor
• Marchman, Janice (D, 15) · primary sponsor
• Amabile, Judy (D, 18)
• Bright, Scott (R, 13)
• Carson, John (R, 30)
• Jodeh, Iman (D, 29)

Latest actions

1. April 22, 2026: House Committee on Health & Human Services Postpone Indefinitely
2. April 21, 2026: Introduced In House - Assigned to Health & Human Services
3. April 13, 2026: Senate Third Reading Passed - No Amendments
4. April 10, 2026: Senate Third Reading Laid Over to 04/13/2026 - No Amendments
5. April 9, 2026: Senate Second Reading Passed - No Amendments
6. April 8, 2026: Senate Second Reading Laid Over to 04/09/2026 - No Amendments
7. April 2, 2026: Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole
8. March 16, 2026: Introduced In Senate - Assigned to Health & Human Services

Votes

• Lay over the bill until May 15th. (April 22, 2026): 11 yea, 0 nay, passed
• Third Reading: BILL (April 13, 2026): 20 yea, 15 nay, passed
• Refer Senate Bill 26-140 to the Committee of the Whole. (April 2, 2026): 5 yea, 2 nay, passed

Common questions

What is SB140?

SB140 is a bill in the Colorado Legislature (2026 Regular Session): Exempt Drugs from Rx Drug Affordability Bd Reviews.

What does SB140 do?

In its own words: A bill FOR AN ACT CONCERNING EXEMPTING CERTAIN DRUGS FROM THE SCOPE OF AFFORDABILITY REVIEWS CONDUCTED BY THE COLORADO PRESCRIPTION DRUG AFFORDABILITY REVIEW BOARD. Bill Summary (Note: This summary applies to this bill as introduced and does not reflect any amendments that may be subsequently adopted…

What is the status of SB140?

Failed as of April 22, 2026. Latest action: House Committee on Health & Human Services Postpone Indefinitely (April 22, 2026).

Who sponsored SB140?

Gilchrist, Lindsay (D, 8), with 11 co-sponsors.

Where is the official record for SB140?

On the Colorado Legislature website: https://leg.colorado.gov/bills/sb26-140